The Business of ADHD Medication

Here is an article about drug maker Shire. Shire is the company which makes Adderall XR and now Vyvanse.
This article points out that Shires approach of creating medication to help with specialists is an approach which seems to be working. It also points out the reality that Shire is aiming to get doctors to write more prescriptions for Vyvanse – because Adderall XR is going ‘generic’ in the near future. (when Adderall XR goes generic, Shire will lose the income that they currently make from it).

Although the medication treatment of ADHD can be controversial – medication treatment can also change people’s lives – i.e. dramatically improve it. This article gives a view into the strategy that a pharmaceutical company is using to protect its income – i.e. trying to switch the market toward vyvanse rather than Adderall XR.

Do you think that this will have an impact on the treatments your doctor offers you?

Enter your thoughts or comments below.

Dr. Kenny

p.s. This is an issue which is going on in the US right now. In Canada, Vyvanse has not even come to market yet – and likely won’t for another 6-18 months…

Technorati Tags: Vyvanse, Adderall XR, ADHD, Medication

Tweet This Post